Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-013879

Options or other derivatives

  • Director acquired 190,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FORBES CHRISTOPHER · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-09-30 Grant or award : show line 1 in the form Common Stock Option +190,000 $0.25 2021-09-30 190,000 931,239 D
Loading xslF345X03/edgar.xml…